Fenofibrate has been used to study its effect on plasma lipids liver phenotype and gene expression to study its impact on endothelium-dependent vasodilatation of thoracic aorta to administer to NASH knock-in mice along with a high fat diet (HFD) to study its effect.

For R&D use onlynot for drug household or other uses.

Fenofibrate marketed as Tricor and under several other brand names is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in people at risk of cardiovascular disease. Like other fibrates it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels as well as increasing high-density lipoprotein (HDL) levels and reducing triglyceride levels. It is used alone or along with statins in the treatment of hypercholesterolemia and hypertriglyceridemia.